Home/Filings/4/0001127602-24-013937
4//SEC Filing

Williams David Michael 4

Accession 0001127602-24-013937

CIK 0000310158other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:11 PM ET

Size

6.2 KB

Accession

0001127602-24-013937

Insider Transaction Report

Form 4
Period: 2024-04-30
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-30+16,40616,406 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (16,406 underlying)
Holdings
  • Common Stock

    19,875.918
Footnotes (2)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001820958

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:11 PM ET
Size
6.2 KB